Tag

Policy analysis

August 12, 2022
Modelling the Microelimination of Chronic Hepatitis C in the Canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy Goals Despite the Impact of the COVID 19 Pandemic
Summary Since 2014, the Swiss Hepatitis Strategy (SHS) has targeted the elimination of Hepatitis C Virus (HCV) in Switzerland. The epidemiology of HCV is diverse across Swiss cantons, therefore cantonal-level screening and treatment strategies should be developed. This study aimed to identify scenarios to achieve HCV elimination in the canton of Bern by 2030. A […]

Read More
May 25, 2022
Impact of Expanding Hepatitis B Treatment Guidelines: A Modelling and Economic Impact Analysis
Summary Antiviral treatment in patients with chronic hepatitis B (CHB) may decrease the risk of hepatocellular carcinoma (HCC) and death. However, only 2.2% of CHB patients receive antiviral treatment globally. The complexity and strictness of the current clinical practice guidelines may limit expanding the treatment coverage for CHB. We examined the impact of expanding treatment […]

Read More
April 29, 2022
Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection
Summary At a time when hepatitis C virus clearance can be obtained by DAAs in almost all infected patients, global infection burden control is an objective within reach, even if achieving the WHO HCV elimination targets by 2030 may not be attainable. The lowest cost intervention is an awareness campaign to bring in those who […]

Read More
April 22, 2022
Ten Years Countdown to Hepatitis C Elimination in Belgium: A Mathematical Modeling Approach
Summary Chronic infection with the hepatitis C virus (HCV) remains a worldwide health problem. As a result, the World Health Organization (WHO) has set elimination targets by 2030. This study aims to examine the position of Belgium in meeting the WHO’s targets by 2030. A Markov disease progression model, constructed in Microsoft Excel, was utilized […]

Read More
March 31, 2022
Updated Epidemiology of Hepatitis C Virus Infections and Implications for Hepatitis C Virus Elimination in Germany
Summary In 2014, an analysis was conducted to evaluate the hepatitis C virus (HCV) epidemiology and disease burden in Germany. Since then, there have been considerable developments in HCV management such as the implementation of direct acting antivirals. The aim of this analysis was to assess the recent data available for Germany, establish an updated […]

Read More
December 1, 2021
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
Summary Background & aims Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent, yet largely underappreciated liver condition which is closely associated with obesity and metabolic disease. Despite affecting an estimated 1 in 4 adults globally, NAFLD is largely absent on national and global health agendas. Methods We collected data from 102 countries, accounting for […]

Read More
July 28, 2020
The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data
Summary Background New hepatitis C virus (HCV) treatments spurred the World Health Organization (WHO) in 2016 to adopt a strategy to eliminate HCV as a public health threat by 2030. To achieve this, key policies must be implemented. In the absence of monitoring mechanisms, this study aims to assess the extent of policy implementation from […]

Read More
July 27, 2020
Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
Summary Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C? In 2019, a Lancet Gastroenterology & Hepatology Commission on accelerating the elimination of viral hepatitis reported on the status of 11 viral hepatitis policy indicators in 66 countries and territories with the heaviest burden by global region. […]

Read More
January 30, 2018
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
Summary Even though WHO has approved global goals for hepatitis elimination, most countries have yet to establish programs for hepatitis B and C, which account for 320 million infections and over a million deaths annually. One reason for this slow response is the paucity of robust, compelling analyses showing that national HBV/HCV programs could have […]

Read More

Tag

Policy analysis

Modelling the Microelimination of Chronic Hepatitis C in the Canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy Goals Despite the Impact of the COVID 19 Pandemic

Impact of Expanding Hepatitis B Treatment Guidelines: A Modelling and Economic Impact Analysis

Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection

Ten Years Countdown to Hepatitis C Elimination in Belgium: A Mathematical Modeling Approach

Updated Epidemiology of Hepatitis C Virus Infections and Implications for Hepatitis C Virus Elimination in Germany

The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data

Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?

The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up

Useful Links, CDAF

Useful Links, Polaris

Latest News